China Healthwise Holdings Limited (0348.HK) Stock

About China Healthwise Holdings Limited

China Healthwise Holdings Limited, an investment holding company, engages in the sale of Chinese health products in Hong Kong. It operates through three segments: Chinese Health Products, Money Lending Business, and Investment in Financial Instruments. The company sells Chinese and other pharmaceutical products, health products, ginseng, and dried seafood products to wholesalers and retailers; and trades and retails Sum Yung and dried seafood under the Nam Pei Hong brand name. It is also involved in money lending business; and invests in financial instruments. The company was formerly known as Haier Healthwise Holdings Limited and changed its name to China Healthwise Holdings Limited in January 2017. China Healthwise Holdings Limited was incorporated in 1997 and is headquartered in Central, Hong Kong.

China Healthwise Holdings Limited (0348.HK) stock trades at $0.08 with a market capitalization of $59.33M. The stock is valued at price-to-book of 1.75, price-to-sales of 0.60. Over the past 52 weeks the stock has ranged between $0.05 and $0.22, and currently trades 63.6% below its 52-week high.

On profitability, China Healthwise Holdings Limited generates an operating margin of 3.52%, a net profit margin of -2.62%.

Official website: www.healthwisehk.com